407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study

Autor: Radosa, J.C., Fietz, T., Wilke, J., Decker, T., Petersen, V., Deryal, M., Knoblich, J., Losem, C., Rhein, U., Schöttker, B., Wrobel, D., Pfeiler, G., Zanucco, E., Buncke, J., Woerner, S., Gratzke, K., Adams, A., Glastetter, E., Bartsch, R., Lux, M.P.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S353-S354
Databáze: ScienceDirect